Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0650 CAD | 0.00% |
|
-7.14% | +8.33% |
17/06 | Declaration of Voting Results by MediPharm Labs | CI |
17/06 | MediPharm Labs Corp. Announces Board Changes | CI |
Capitalization | 2.7Cr 1.97Cr 1.69Cr 1.57Cr 1.45Cr 169.07Cr 3Cr 19Cr 7.18Cr 79Cr 7.39Cr 7.24Cr 288.74Cr | P/E ratio 2025 * |
-
| P/E ratio 2026 * | - |
---|---|---|---|---|---|
Enterprise value | 2.7Cr 1.97Cr 1.69Cr 1.57Cr 1.45Cr 169.07Cr 3Cr 19Cr 7.18Cr 79Cr 7.39Cr 7.24Cr 288.74Cr | EV / Sales 2025 * |
0.58x | EV / Sales 2026 * | 0.5x |
Free-Float |
94.64% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: MediPharm Labs Corp.
More press releases
1 week | -7.14% | ||
Current month | -7.14% | ||
1 month | -18.75% | ||
3 months | -23.53% | ||
6 months | -13.33% | ||
Current year | +8.33% |
1 week | 0.06 | ![]() | 0.07 |
1 month | 0.06 | ![]() | 0.08 |
Current year | 0.06 | ![]() | 0.12 |
1 year | 0.06 | ![]() | 0.12 |
3 years | 0.06 | ![]() | 0.12 |
5 years | 0.06 | ![]() | 1.25 |
10 years | 0.06 | ![]() | 7.39 |
Manager | Title | Age | Since |
---|---|---|---|
David Pidduck
CEO | Chief Executive Officer | - | 20/04/2022 |
Greg Hunter
DFI | Director of Finance/CFO | - | 08/02/2021 |
William Gordon
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/2016 |
Director | Title | Age | Since |
---|---|---|---|
Chris Taves
CHM | Chairman | - | 17/08/2021 |
Chris Halyk
BRD | Director/Board Member | - | 04/08/2020 |
David Pidduck
BRD | Director/Board Member | - | 20/04/2022 |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
0.00% | -7.14% | -7.14% | +8.33% | 1.97Cr | ||
+3.89% | +22.33% | -48.51% | -58.16% | 86Cr | ||
+22.22% | +44.74% | -67.96% | -74.65% | 75Cr | ||
+15.00% | +15.00% | +27.78% | -56.05% | 42Cr | ||
Average | +10.28% | +5.70% | -23.96% | -45.13% | 51.1Cr | |
Weighted average by Cap. | +12.81% | +11.85% | -39.64% | -63.11% |
2025 * | 2026 * | |
---|---|---|
Net sales | 4.63Cr 3.38Cr 2.89Cr 2.7Cr 2.49Cr 289.94Cr 5.15Cr 32Cr 12Cr 135.47Cr 13Cr 12Cr 495.16Cr | 5.36Cr 3.91Cr 3.35Cr 3.12Cr 2.89Cr 335.68Cr 5.96Cr 37Cr 14Cr 156.85Cr 15Cr 14Cr 573.27Cr |
Net income | -14.66L -10.71L -9L -9L -8L -9.18Cr -16.32L -1.02Cr -38.99L -4.29Cr -40.16L -39.34L -16Cr | 6L 5L 4L 4L 3L 4.05Cr 7L 45.01L 17.19L 1.89Cr 17.71L 17.34L 6.91Cr |
Net Debt | - | - |
More financial data
* Estimated data
Employees
161
Sector
Pharmaceuticals
Calendar
Date | Price | Change | Volume |
---|---|---|---|
10/25/10 | 0.0650 $ | 0.00% | 58,653 |
09/25/09 | 0.0650 $ | 0.00% | 1,45,211 |
08/25/08 | 0.0650 $ | 0.00% | 25,436 |
07/25/07 | 0.0650 $ | 0.00% | 1,03,268 |
04/25/04 | 0.0650 $ | 0.00% | 1,20,312 |
Delayed Quote Toronto S.E., July 11, 2025 at 01:29 am IST
More quotesSell
Buy

Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.0650
Average target price
-
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LABS Stock
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition